Industry Insights

  1. The Transformation To Single-Use Excellence

    How a customer focused mission to boost single-use assembly product quality and supply security led to the Mobius® MyWay Program and a  manufacturing site transformation.

  2. Collaboration With Third Parties And Its Impact On Document Management

    Collaboration takes many forms; this article will look at how document production, distribution and archiving are affected by the virtual pharma model and in clinical and manufacturing quality settings.

  3. Designing A Biomanufacturing Facility Incorporating Single-Use Technologies

    When building a new facility based on single-use technologies, or incorporating single-use into an existing facility, how do companies ensure they fully realize the benefits?

  4. Overcoming Purification Hurdles With Mixed-Mode Chromatography

    Current production systems can generate high titers of adenovirus, however, adenoviral vectors are tricky to purify on any significant scale despite their availability and abundance.

  5. Don’t Let Insufficient Data Undermine Your CMO & CRO Selection Processes

    Selecting a partner is challenging, but with the right information you can simplify your efforts and increase your likelihood of making the best decision. 

  6. RABS vs. Isolator – Technology and Applications

    Considerable confusion still surrounds the terms barrier, Restricted Access Barrier System, and isolator and their respective suitability and favorability in pharmaceutical fill-finish operations. 

  7. Let The Molecule Decide

    Formulation techniques and technologies can easily become more habit than science, but a single technology does not work for all compounds. Each new drug is unique and deserves a fresh approach to formulation.

  8. Getting Ready For Phase 1 In Pharmaceutical Development

    At the early stages of product development, pharmaceutical development scientists are under increasing time pressure to select the right molecule form, the right formulation and the right final dose form.

  9. The Next Generation Of Bioprocess Engineering: Bringing A Perspective From The Last Two Decades

    The increasing complexity of bioprocess engineering has driven a shift toward cell biology and away from process engineering.  Cell types have become more diverse, the science more complex, and genetic modifications more common, all while products are becoming more targeted and cost effective.   What should we expect to see from industry and academia to keep the field moving forward?

  10. Accelerate Biopharmaceutical Development With Novel Analytical Techniques

    This article explains how using an Octet-based Fc receptor panel may help developers achieve a faster assessment of monoclonal antibody functionality, well before the final molecule is selected.